Market Research Logo

Global mRNA Vaccines & Therapeutics Market Research Report 2018

Global mRNA Vaccines & Therapeutics Market Research Report 2018

This report studies the mRNA Vaccines & Therapeutics market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the mRNA Vaccines & Therapeutics market by product type and applications.

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

The major players in global mRNA Vaccines & Therapeutics market include
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology

Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of mRNA Vaccines & Therapeutics in these regions, from 2020 to 2030 (forecast), covering
North America
Europe
Asia Pacific
South America
Middle East and Africa

On the basis on the end users/applications, this report covers
Infectious Disease
Cancer
Other


1 mRNA Vaccines & Therapeutics Market Overview
1.1 Product Overview and Scope of mRNA Vaccines & Therapeutics
1.2 Global mRNA Vaccines & Therapeutics Market by Applications/End Users
1.2.1 Global mRNA Vaccines & Therapeutics Expenses Comparison by Applications
1.2.2 Infectious Disease
1.2.3 Cancer
1.3 Global mRNA Vaccines & Therapeutics Revenue (2020-2030)
1.4 Global mRNA Vaccines & Therapeutics Market by Regions
1.4.1 Global mRNA Vaccines & Therapeutics Revenue Comparison by Regions (2020-2030)
1.4.2 North America mRNA Vaccines & Therapeutics Status and Prospect (2020-2030)
1.4.3 Europe mRNA Vaccines & Therapeutics Status and Prospect (2020-2030)
1.4.4 Asia Pacific mRNA Vaccines & Therapeutics Status and Prospect (2020-2030)
1.4.5 South America mRNA Vaccines & Therapeutics Status and Prospect (2020-2030)
1.4.6 Middle East and Africa mRNA Vaccines & Therapeutics Status and Prospect (2020-2030)
2 Global mRNA Vaccines & Therapeutics Market Competition by Manufacturers
2.1 Global mRNA Vaccines & Therapeutics Market Competition by Players
2.2 R&D Share (%) Analysis
2.2.1 2013-2018E Global mRNA Vaccines & Therapeutics R&D Share (%)
2.2.2 2017-2018 mRNA Vaccines & Therapeutics R&D Share (%) Analysis (Company Segment)
2.3 Pipeline Analysis of mRNA Vaccines & Therapeutics
2.4 Main Pipeline Product Analysis
2.4.1 IVAC-Mutanome
2.4.2 FixVax
2.4.3 CV8102
2.4.4 CV7201
2.4.5 AGS-004
2.4.6 MRT5005 & MRT5201
2.4.7 SB-FIX & SB-318 & SB-913
2.4.8 mRNA-1647
2.4.9 mRNA-4157
2.4.10 mRNA-1653
3 Major Cancer Analysis
3.1 Colorectal Cancer
3.1.1 Colorectal Cancer Introduction
3.1.2 Introduction of the Number of Patients with Colorectal Cancer
3.2 Lung Cancer
3.2.1 Lung Cancer Introduction
3.2.2 Introduction of the Number of Patients with Lung Cancer
3.3 Pancreatic Cancer
3.3.1 Pancreatic Cancer Introduction
3.3.2 Introduction of the Number of Patients with Pancreatic Cancer
3.4 Breast Cancer
3.4.1 Breast Cancer Introduction
3.4.2 Introduction of the Number of Patients with Breast Cancer
3.5 Prostate Cancer
3.5.1 Prostate Cancer Introduction
3.5.2 Introduction of the Number of Patients with Prostate Cancer
3.6 Other Cancer
4 Global mRNA Vaccines & Therapeutics Expenses by Region (2013-2018)
4.1 Global mRNA Vaccines & Therapeutics Expenses by Regions
4.2 North America mRNA Vaccines & Therapeutics Market
4.2.1 North America mRNA Vaccines & Therapeutics Expense (2013-2018)
4.2.2 North America mRNA Vaccines & Therapeutics Expense and Market Share by Players
4.3 Europe mRNA Vaccines & Therapeutics Market
4.3.1 Europe mRNA Vaccines & Therapeutics Expenses (2013-2018)
4.3.2 Europe mRNA Vaccines & Therapeutics Expenses and Market Share by Players
5 Global mRNA Vaccines & Therapeutics Segment Market Analysis (by Application)
5.1 Global mRNA Vaccines & Therapeutics Expenses by Application
5.2 North America mRNA Vaccines & Therapeutics Expense and Market Share by Applications
5.3 Europe mRNA Vaccines & Therapeutics Expenses and Market Share by Applications
6 Company Profiles
6.1 Companies with mRNA Programs
6.1.1 Alexion Pharmaceuticals
6.1.2 Vertex Pharmaceuticals
6.1.3 Ultragenyx Pharmaceutical
6.2 Companies focus on mRNA Delivery
6.2.1 Acuitas Therapeutics
6.2.2 Silence Therapeutics
6.2.3 Arcturus Therapeutics
7 Analysis of mRNA Vaccines & Therapeutics Industry Key Manufacturers
7.1 Moderna Therapeutics
7.1.1 Company Profile
7.1.2 Product Information
7.1.3 Expenses, R&D Share
7.2 CureVac
7.2.1 Company Profile
7.2.2 Product Information
7.2.3 Expenses, R&D Share
7.3 RaNa Therapeutics (Translate Bio)
7.3.1 Company Profile
7.3.2 Product Information
7.3.3 Expenses, R&D Share
7.4 BioNTech
7.4.1 Company Profile
7.4.2 Product Information
7.4.3 Expenses, R&D Share
7.5 Sangamo Therapeutics
7.5.1 Company Profile
7.5.2 Product Information
7.5.3 Expenses, R&D Share
7.6 Argos Therapeutics
7.6.1 Company Profile
7.6.2 Product Information
7.6.3 Expenses, R&D Share
7.7 In-Cell-Art
7.7.1 Company Profile
7.7.2 Product Information
7.7.3 Expenses, R&D Share
7.8 eTheRNA
7.8.1 Company Profile
7.8.2 Product Information
7.8.3 Expenses, R&D Share
7.9 Ethris
7.9.1 Company Profile
7.9.2 Product Information
7.9.3 Expenses, R&D Share
7.10 Tiba Biotechnology
7.10.1 Company Profile
7.10.2 Product Information
7.10.3 Expenses, R&D Share
8 mRNA Vaccines & Therapeutics Manufacturing Cost Analysis
8.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis
8.1.1 Clinical Phase Costs
8.1.2 Capitalized Costs
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.2.1 USA Labor Cost Analysis
8.2.2.2 Europe Labor Costs Analysis
8.2.2.3 Asia Labor Costs Analysis
8.2.3 Other Costs Analysis
8.2.3.1 USA Cost of Electricity Analysis
8.2.3.2 USA Water Cost Analysis
8.2.3.3 Europe Cost of Electricity Analysis
8.2.3.4 Europe Water Cost Analysis
8.2.3.5 China Cost of Electricity Analysis
8.2.3.6 China Water Cost Analysis
8.2.4 Manufacturing Expenses
8.3 Comparison of Production Processes for Traditional, mRNA and DNA vaccines
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 mRNA Vaccines & Therapeutics Discovery and Development Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 DNA/mRNA Advantages over Traditional Vaccines
10.3 Major Pharmaceutical Companies with mRNA Programs
10.3.1 Boehringer Ingelheim
10.3.2 Novartis
10.3.3 Merck
10.3.4 AstraZeneca
10.3.5 Roche
10.3.6 Sanofi
10.3.7 Takeda
10.3.8 Johnson & Johnson
10.3.9 Bayer
10.3.10 ZIOPHARM Oncology
10.3.11 MaxCyte
10.3.12 Casebia Therapeutics
10.3.13 Intellia Therapeutics
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Pipeline Analysis of Global RNAi for Therapeutic Key Manufacturers
11.1.2.1 Alnylam Pharmaceuticals Pipeline Analysis of RNAi for Therapeutic
11.1.2.2 Arbutus Biopharma (Tekmira) Pipeline Analysis of RNAi for Therapeutic
11.1.2.3 Arrowhead Research Pipeline Analysis of RNAi for Therapeutic
11.1.2.4 Dicerna Pharmaceuticals Pipeline Analysis of RNAi for Therapeutic
11.1.2.5 Mirna Therapeutics Pipeline Analysis of RNAi for Therapeutic
11.1.2.6 Quark Pharmaceuticals Pipeline Analysis of RNAi for Therapeutic
11.1.2.7 RXi Pharmaceuticals Pipeline Analysis of RNAi for Therapeutic
11.1.2.8 Silence Therapeutics Pipeline Analysis of RNAi for Therapeutic
11.1.2.9 Benitec Biopharma Pipeline Analysis of RNAi for Therapeutic
11.1.2.10 miRagen Therapeutics Pipeline Analysis of RNAi for Therapeutic
11.1.2.11 Sylentis Pipeline Analysis of RNAi for Therapeutic
11.1.2.12 Gradalis Pipeline Analysis of RNAi for Therapeutic
11.1.2.13 Sirnaomics Pipeline Analysis of RNAi for Therapeutic
11.1.2.14 Silenseed Pipeline Analysis of RNAi for Therapeutic
11.2 Consumer Needs/Customer Preference Change
11.2.1 Considerations for both Early and Late Phase Clinical Trials
11.2.2 Considerations for Early Phase Clinical Trials
11.2.3 Considerations for Late Phase Clinical Trials
11.3 Economic/Political Environmental Change
12 Global mRNA Vaccines & Therapeutics Market Forecast (2020-2030)
12.1 Global mRNA Vaccines & Therapeutics Revenue Forecast (2020-2030)
12.2 Global mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast by Regions (2020-2030)
12.2.1 Global mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast (2020-2030)
12.2.2 North America mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast (2020-2030)
12.2.3 Europe mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast (2020-2030)
12.2.4 Asia Pacific mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast (2020-2030)
12.2.5 South America mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast (2020-2030)
12.2.6 Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast (2020-2030)
12.3 Global mRNA Vaccines & Therapeutics Revenue Forecast by Application (2020-2030)
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
List of Tables and Figures
Figure Product Picture of mRNA Vaccines & Therapeutics
Table Scope of Clinical mRNA Applications
Figure Global Expenses Market Share of mRNA Vaccines & Therapeutics by Applications in 2017
Figure Infectious Disease Examples
Figure Cancer Examples
Figure Global mRNA Vaccines & Therapeutics Revenue (M USD) and Growth Rate (2020-2030)
Figure Global Market mRNA Vaccines & Therapeutics Revenue (M USD) Comparison by Regions 2020-2030
Figure North America mRNA Vaccines & Therapeutics Revenue (M USD) and Growth Rate (2020-2030)
Figure Europe mRNA Vaccines & Therapeutics Revenue (M USD) and Growth Rate (2020-2030)
Figure Asia Pacific mRNA Vaccines & Therapeutics Revenue (M USD) and Growth Rate (2020-2030)
Figure South America mRNA Vaccines & Therapeutics Revenue (M USD) and Growth Rate (2020-2030)
Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue (M USD) and Growth Rate (2020-2030)
Table Global mRNA Vaccines & Therapeutics Expenses (M USD) of Key Players (2017-2018)
Table Global mRNA Vaccines & Therapeutics Expenses Market Share by Players (2017-2018)
Figure 2017 Global mRNA Vaccines & Therapeutics Expenses Market Share by Players
Figure 2018 Global mRNA Vaccines & Therapeutics Expenses Market Share by Players
Figure 2013-2018E Global mRNA Vaccines & Therapeutics R&D Share (%)
Table 2017-2018 Global mRNA Vaccines & Therapeutics R&D Share (%) List (Company Segment)
Table Pipeline Analysis mRNA Vaccines & Therapeutics
Figure IVAC-Mutanome Pipeline
Figure FixVax Pipeline
Figure CV8102 Pipeline
Figure CV7201 Pipeline
Figure CV7201 Pipeline
Figure MRT5005 & MRT5201 Pipeline
Figure SB-FIX Pipeline
Figure SB-318 & SB-913 Pipeline
Figure mRNA-1647 Pipeline
Figure mRNA-4157 Pipeline
Figure mRNA-1653 Pipeline
Top 20 Countries Highest Incidence of Colorectal Cancer in 2016
Top 20 Countries Highest Incidence of Lung Cancer in 2016
Figure Percent of New Cases by Age Group: Lung Cancer
Figure Percent of Deaths by Age Group: Lung Cancer
Top 20 Countries Highest Incidence of Pancreatic Cancer in 2016
Top 20 Countries Highest Incidence of Breast Cancer in 2016
Figure Percent of New Cases by Age Group: Prostate Cancer
Figure Percent of Deaths by Age Group: Prostate Cancer
Figure Estimated Prostate Cancer Incidence Worldwide in 2016
Information about World Cancer Statistics for the Most Common Cancers (excluding non-melanoma Skin Cancer) in 2016
Table Global mRNA Vaccines & Therapeutics Expenses (M USD) and Market Share by Regions (2013-2018)
Table Global mRNA Vaccines & Therapeutics Expenses Market Share by Regions (2013-2018)
Figure Expenses Market Share of mRNA Vaccines & Therapeutics by Regions (2013-2018)
Figure Global mRNA Vaccines & Therapeutics Expenses Market Share by Regions in 2017
Figure North America mRNA Vaccines & Therapeutics Expenses (M USD) and Growth Rate (2013-2018)
Table North America mRNA Vaccines & Therapeutics Expenses (M USD) by Players (2017-2018)
Table North America mRNA Vaccines & Therapeutics Expenses Market Share by Players (2017-2018)
Figure North America mRNA Vaccines & Therapeutics Expenses Market Share by Players in 2017
Figure Europe mRNA Vaccines & Therapeutics Expenses (M USD) and Growth Rate (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Expenses (M USD) by Players (2017-2018)
Table Europe mRNA Vaccines & Therapeutics Expenses Market Share by Players (2017-2018)
Figure Europe mRNA Vaccines & Therapeutics Expenses Market Share by Players in 2017
Table Global mRNA Vaccines & Therapeutics Expenses (M USD) by Application (2013-2018)
Table Global mRNA Vaccines & Therapeutics Expenses Market Share by Application (2013-2018)
Figure Expenses Market Share of mRNA Vaccines & Therapeutics by Application (2013-2018)
Figure Global mRNA Vaccines & Therapeutics Expenses Market Share by Application in 2017
Table North America mRNA Vaccines & Therapeutics Expenses (M USD) by Applications (2013-2018)
Table North America mRNA Vaccines & Therapeutics Expenses Market Share by Applications (2013-2018)
Figure North America mRNA Vaccines & Therapeutics Expenses Market Share by Applications in 2017
Table Europe mRNA Vaccines & Therapeutics Expenses (M USD) by Applications (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Expenses Market Share by Applications (2013-2018)
Figure Europe mRNA Vaccines & Therapeutics Expenses Market Share by Applications in 2017
Table Alexion Pharmaceuticals Company Profile
Table Vertex Pharmaceuticals Company Profile
Table Ultragenyx Pharmaceutical Company Profile
Table Acuitas Therapeutics Company Profile
Figure mRNA Vaccines & Therapeutics Product Information of Acuitas

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook